Scam Alert « ScamFraudAlert WebBlog

Account Processing [Flexible hours - $2000 monthly] November 23, 2009

Posted by Scrub in Alerts, Consumer Awareness, Consumer Watch, Employment Alert, Fraudulent Job Offer, Job Offer Scam, Job Scam, Scam Alert, Work At Home Scam.
Tags: Money Mule, Work At Home Job Alert
add a comment

The Purpose of This Post Is To ALERT You That The Job You Are About To APPLY For or May Have Applied For or is CONSIDERING APPLYING For Is Scam Alert 1 Fraudulent. A LEGITIMATE COMPANY IDENTITY OR AN INDIVIDUAL IDENTITY HAS BEEN STOLEN OR A BOGUS ONE CREATED

These job postings are an attempt to lure you into cashing counterfeit checks and have you wire funds via Western Union or MoneyGram -Essentially You Become A Money or RePackage Mule

Money Mule Explained

Washingtonpost.com by Brian Kerbs

Date: 2009-11-21, 6:15PM PST

Reply to: job-fc8j4-1476905750@craigslist.org [Errors when replying to ads?]

We have a position available. This job is about organizing and maintaining product information, being in touch with manager, sending out correspondence and various other administrative duties.

The preferred applicants should be at least 25 years old with a strong internet access. The ideal candidate must be articulate, highly motivated, and detail oriented associate who will be a member of our geographically dispersed team. We would like to point out that this job may become a great additional employment for you. You may have a primary employment or a running business and still cooperate with us because this job would not take a lot of your time.

Please send your resume directly to corp.employment@gmail.com

Compensation: Salary: $1790.00 – $3790.00/month
Telecommuting is ok.
This is a part-time job.
This is a contract job.
Principals only. Recruiters, please don’t contact this job poster.
Please, no phone calls about this job!
Please do not contact job poster about other services, products or commercial interests.
PostingID: 1476905750

$200/Day – Accounts Payable / Data Entry Online November 23, 2009

Posted by Scrub in Alerts, Consumer Alert, Consumer Awareness, Consumer Protection, Consumer Watch, Employment Alert, Fake Job Offers, Scam Alert, Work At Home Scam.
Tags: Work At Home Job Alert
add a comment

Bogus Employment Offer

This is a work at home opportunity and we are looking for individuals who are willing to work from home.

No experience is needed, we will take care of the training. Paychecks are guaranteed.

Full time/part time positions are available now.

How Does This Work?

Thousands of companies have contracted their data entry needs to us. As a results, we need to hire more individuals to help us process that data.

Large fortune 500 companies need forms written up such as, receipt forms, brochures, customer lists, e-mailing lists, etc.

You are paid twice monthly (1st and 16th of each month). You have the option of direct deposit or check. After 1 month, average data processors assistants make $15,000/mo.

ENTER HERE TO GET STARTED

Requirements

*You need an internet connection or access to the internet.
* Experience is not needed however, you need to be capable of working from home – This is not a desk job nor do you commute to an office.
*We do not require any special skills, previous business experience or education. We only require that you have basic typing skills.
*Doing data entry work is ideal because it pays very well, but also it is not very time demanding.
*Many of our employees are work at home moms, students, unemployed individuals and former retirees.
*Full time and part time positions are available.

ENTER HERE TO GET STARTED

WhoIs – findthemmedsherenow.com November 23, 2009

Posted by Scrub in Alerts, Bogus Pharmacy Sites, Canadian Pharmacy Alert, Consumer Alert, Consumer Protection, Consumer Watch, Counterfeit Drugs Alert, Fraud Alert, Malware, Online Pharmacy Alert, Pharmacy Alert - PharmAlert, Phishing & Identity Theft, Scam Alert, Spyware, Trojan.
Tags: Fake Jobs
add a comment

Buying Prescription Drugs Online
May Be Dangerous
Says Drug Enforcement Administration

National Association of Boards of Pharmacy (NABP)

Warning

“The Canadian Pharmacy, Canadian/European Pharmacy”, “Canadian Healthcare” and “US Drugstore” are brands of one of the most disgusting illegal online pharmacy group well organized CRIMINAL OPERATION of all times. “GREED” is the driving force behind this operation. Don’t let them fool you. They will never send you any genuine drugs. If they ever send anything at all, it may consist of literally anything from sugar to wall plaster, and they certainly don’t care that you will endanger your health by taking those dangerous counterfeit drugs.

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

There are many options out there when it comes to buying medication online. We have looked at websites after websites. Some sites feature offshore pharmacies that do not require a prior prescription. Others feature licensed pharmacies that do require a prescription from your doctor.
Before making a purchase that can effect your health, we strongly recommend that you consult your physician & DO NOT self-medicate. Ordering medication online can be a safe, money-saving experience. When done through licensed online pharmacies that require a prescription, you can be assured that the medication you get is exactly what you need to treat your ailments.

Order your favorite RxMedications 0nline!
No doctor needed!
Browse our selection today! -> http://findthemmedsherenow.com

Address lookup

canonical name	findthemmedsherenow.com.
aliases
addresses	222.170.127.122

Domain Whois record

Queried whois.internic.net with “dom findthemmedsherenow.com”…
Domain Name: FINDTHEMMEDSHERENOW.COM
Registrar: CHINA SPRINGBOARD INC.
Whois Server: whois.namerich.cn
Referral URL: http://www.namerich.cn
Name Server: NS1.91UKRAINE.COM
Name Server: NS2.91UKRAINE.COM
Name Server: NS3.LIKENS45.COM
Name Server: NS4.LIKENS45.COM
Name Server: NS5.ANTRASCRNS.COM
Name Server: NS6.ANTRASCRNS.COM
Status: clientDeleteProhibited
Status: clientTransferProhibited
Updated Date: 17-nov-2009
Creation Date: 30-sep-2009
Expiration Date: 30-sep-2010

Last update of whois database: Mon, 23 Nov 2009 12:21:27 UTC
Queried whois.namerich.cn with “findthemmedsherenow.com”…
DomainName : findthemmedsherenow.com

RSP: China Springboard Inc.
URL: http://www.namerich.cn

Name Server :NS2.91UKRAINE.COM
Name Server :NS4.LIKENS45.COM
Name Server :NS5.ANTRASCRNS.COM
Name Server :NS1.91UKRAINE.COM
Name Server :NS6.ANTRASCRNS.COM
Name Server :NS3.LIKENS45.COM
Status :clientTransferProhibited
Status :clientDeleteProhibited
Creation Date :2009-10-01
Expiration Date :2010-10-01
Last Update Date :2009-11-18

Registrant ID :V-X-63774-22022
Registrant Name :LIN YIXIA
Registrant Organization :LINYIXIA
Registrant Address :chongjiangxilu42
Registrant City :JN
Registrant Province/State :ShanDong
Registrant Country Code :CN
Registrant Postal Code :250069
Registrant Phone Number :+86.053181416841
Registrant Fax :+86.053181416841
Registrant Email :kuledeliu@126.com

Administrative ID :V-X-63774-22022
Administrative Name :LIN YIXIA
Administrative Organization :LINYIXIA
Administrative Address :chongjiangxilu42
Administrative City :JN
Administrative Province/State :ShanDong
Administrative Country Code :CN
Administrative Postal Code :250069
Administrative Phone Number :+86.053181416841
Administrative Fax :+86.053181416841
Administrative Email :kuledeliu@126.com

Billing ID :V-X-63774-22022
Billing Name :LIN YIXIA
Billing Organization :LINYIXIA
Billing Address :chongjiangxilu42
Billing City :JN
Billing Province/State :ShanDong
Billing Country Code :CN
Billing Postal Code :250069
Billing Phone Number :+86.053181416841
Billing Fax :+86.053181416841
Billing Email :kuledeliu@126.com

Technical ID :V-X-63774-22022
Technical Name :LIN YIXIA
Technical Organization :LINYIXIA
Technical Address :chongjiangxilu42
Technical City :JN
Technical Province/State :ShanDong
Technical Country Code :CN
Technical Postal Code :250069
Technical Phone Number :+86.053181416841
Technical Fax :+86.053181416841
Technical Email :kuledeliu@126.com

; Please register your domains at
; http://www.namerich.cn

Network Whois record

Queried whois.apnic.net with “222.170.127.122″…
inetnum: 222.170.0.0 – 222.172.127.255
netname: CHINANET-HL
descr: CHINANET HEILONGJIANG PROVINCE NETWORK
descr: Heilongjiang Telecom Corporation
descr: NO.178 Zhongshan Road,Haerbin,Heilongjiang 150040
country: CN
admin-c: LZ298-AP
tech-c: CH93-AP
mnt-by: APNIC-HM
mnt-lower: MAINT-CHINANET-HL
mnt-routes: MAINT-CHINANET-HL
remarks: -+-+-+-+-+-+-+-+-+-+-+-++-+-+-+-+-+-+-+-+-+-+-+-+-+-+
remarks: This object can only be updated by APNIC hostmasters.
remarks: To update this object, please contact APNIC
remarks: hostmasters and include your organisation’s account
remarks: name in the subject line.
remarks: -+-+-+-+-+-+-+-+-+-+-+-++-+-+-+-+-+-+-+-+-+-+-+-+-+-+
status: ALLOCATED PORTABLE
changed: hm-changed@apnic.net 20040305
changed: hm-changed@apnic.net 20060605
source: APNIC

person: LIJUAN ZHENG
nic-hdl: LZ298-AP
e-mail: network@hljtele.com
address: Communication Corporation Internet Enterprise Division of HLJ
phone: +86-451-53902002
fax-no: +86-451-53900012
country: CN
changed: jxwx1234@163.com 20061229
mnt-by: MAINT-CHINANET-HLJTELE
source: APNIC

person: Chinanet Hostmaster
nic-hdl: CH93-AP
e-mail: anti-spam@ns.chinanet.cn.net
address: No.31 ,jingrong street,beijing
address: 100032
phone: +86-10-58501724
fax-no: +86-10-58501724
country: CN
changed: dingsy@cndata.com 20070416
mnt-by: MAINT-CHINANET
source: APNIC

DNS records

DNS query for 122.127.170.222.in-addr.arpa returned an error from the server: NameError

name

class

type

data

time to live

findthemmedsherenow.com

SOA

server:	ns.findthemmedsherenow.com
email:	admin.findthemmedsherenow.com
serial:	2009100101
refresh:	300
retry:	300
expire:	14400
minimum ttl:	300

300s

(00:05:00)

findthemmedsherenow.com

222.170.127.122

300s

(00:05:00)

– end –

Business Representative – Moonbeam Logistics, Inc – moonbeam-logistics.com November 23, 2009

Posted by Scrub in Alerts, Consumer Alert, Consumer Protection, Consumer Watch, Employment Alert, Fake Job Offers, Fraud Alert, Job Scam, Questionable Job Offer, Scam Alert, Scam Job Alert.
Tags: Money Mule
add a comment

The Purpose of This Post Is To ALERT You That The Job You Are About To APPLY For or May Have Applied For or is CONSIDERING APPLYING For Is Fraudulent. A LEGITIMATE COMPANY IDENTITY OR AN INDIVIDUAL IDENTITY HAS BEEN STOLEN OR A BOGUS ONE CREATED

These job postings are an attempt to lure you into cashing counterfeit checks and have you wire funds via Western Union or MoneyGram -Essentially You Become A Money or RePackage Mule

Money Mule Explained

Read All About This at Symantec Corp.

Washingtonpost.com by Brian Kerbs

Date: 2009-10-21, 4:18PM CDT
Reply to: see below

Moonbeam Logistics, Inc. is seeking a full-time operations manager for immediate employment. Please visit our Website at http://www1.moonbeam-logistics.com and understand what we do. Then ask yourself: Am I a self-starter who works well with minimal supervision? Am I known for my organizational skills, positive attitude, and strong work ethic? Do I take pride in the quality of my work and the quality of my employer’s products and services? If the answer to these questions is YES, you could be just the individual we’re looking for.

The successful candidate will be able think on his or her feet and thrive in a fast-paced environment, where juggling multiple deliverables and deadlines is routine. He or she will manage a growing team of 10+ production professionals creating time-sensitive products and services for both wireless carriers and industry associations.

The operations manager:
o Coordinates all day-to-day operations functions
o Balances production deadlines to ensure timeliness of deliverables
o Compiles and presents to management weekly operations status reports
o Develops, maintains, and documents all internal operations processes and procedures

Required skills and qualifications include:
o Ability to perform effectively with minimal supervision
o Strong writing skills

Although unessential, knowledge of the wireless communications environment and wireless media would be helpful. Moonbeam Logistics offers a competitive compensation package commensurate with the selected candidate’s experience and skills. Please direct all inquiries to: http://www1.moonbeam-logistics.com/careers/open/?id=1852

Every month, our team of highly trained media analysts intercepts in marketuas the consumer experiences themumore than 25,000 PSMS advertising campaigns and audits the associated creative for compliance with Mobile Marketing Association Consumer Best Practices and carrier-specific policies. Then, we report our findings to our carrier clients and assist with enforcing established standards. In addition, Moonbeam Logistics analysts audit and report on SMS message flows generated during program opt-in and participation and assist carriers with PSMS program preapproval services and industry consulting services.

* Compensation: $2,800 per month
* Principals only. Recruiters, please don’t contact this job poster.
* Phone calls about this job are ok.
* Please do not contact job poster about other services, products or commercial interests.

PostingID: 1431797732

Canadian Pharmacy Spam – healththeeasierway.com November 23, 2009

Posted by Scrub in Alerts, Bogus Pharmacy Sites, Canadian Pharmacy Alert, Consumer Alert, Consumer Protection, Consumer Watch, Counterfeit Drugs Alert, Fraud Alert, Malware, Pharmacy Alert - PharmAlert, Phishing & Identity Theft, Prescription Drug Review, Prescription Drugs Alert, Scam Alert, Spyware.
Tags: Online Canadian Pharmacy
add a comment

Buying Prescription Drugs Online May Be Dangerous Says Drug Enforcement Administration

National Association of Boards of Pharmacy (NABP)

Warning

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

A Great Selection of Rx~Medicationz are available at your fingertipz!
Browse Our Selection_Today! -> http://healththeeasierway.com

WHOIS – healththeeasierway.com

Registrar: CHINA SPRINGBOARD INC.

Status: clientDeleteProhibited
Dates: Created 16-sep-2009 Updated 20-oct-2009 Expires 16-sep-2010
DNS Servers: NS1.UBR34NS.COM NS2.UBR34NS.COM NS3.BIDOKODJU.COM NS4.BIDOKODJU.COM NS5.HOSTLIFE45.COM NS6.HOSTLIFE45.COM

I was referred to whois.namerich.cn; I’m looking it up there.

Using 9 day old cached answer (or, you can get fresh results).
Displaying E-mail address (use sparingly — this will make it more likely that you will trigger our rate limiting system).

DomainName : healththeeasierway.com

RSP: China Springboard Inc.
URL: http://www.namerich.cn

Name Server :NS5.HOSTLIFE45.COM
Name Server :NS1.UBR34NS.COM
Name Server :NS2.UBR34NS.COM
Name Server :NS4.BIDOKODJU.COM
Name Server :NS6.HOSTLIFE45.COM
Name Server :NS3.BIDOKODJU.COM
Status :clientTransferProhibited
Status :clientDeleteProhibited
Creation Date :2009-09-16
Expiration Date :2010-09-16
Last Update Date :2009-10-21

Registrant ID :V-X-58522-14215
Registrant Name :ZHANG WENQI
Registrant Organization :ZHANG WENQI
Registrant Address :JIAOTONGLU16
Registrant City : D L
Registrant Province/State :LN
Registrant Country Code :CN
Registrant Postal Code :116049
Registrant Phone Number :+86.041128805621
Registrant Fax :+86.041128805621
Registrant Email :kaokga@126.com

Administrative ID :V-X-58522-14215
Administrative Name :ZHANG WENQI
Administrative Organization :ZHANG WENQI
Administrative Address :JIAOTONGLU16
Administrative City : D L
Administrative Province/State :LN
Administrative Country Code :CN
Administrative Postal Code :116049
Administrative Phone Number :+86.041128805621
Administrative Fax :+86.041128805621
Administrative Email :kaokga@126.com

Billing ID :V-X-58522-14215
Billing Name :ZHANG WENQI
Billing Organization :ZHANG WENQI
Billing Address :JIAOTONGLU16
Billing City : D L
Billing Province/State :LN
Billing Country Code :CN
Billing Postal Code :116049
Billing Phone Number :+86.041128805621
Billing Fax :+86.041128805621
Billing Email :kaokga@126.com

Technical ID :V-X-58522-14215
Technical Name :ZHANG WENQI
Technical Organization :ZHANG WENQI
Technical Address :JIAOTONGLU16
Technical City L
Technical Province/State :LN
Technical Country Code :CN
Technical Postal Code :116049
Technical Phone Number :+86.041128805621
Technical Fax :+86.041128805621
Technical Email :kaokga@126.com

; Please register your domains at
; http://www.namerich.cn

FDA Warns of Bogus Pharmacy Site – Trustmeds.com November 22, 2009

Posted by Scrub in Alerts, Bogus Pharmacy Sites, Canadian Pharmacy Alert, Consumer Alert, Consumer Awareness, Consumer Protection, Consumer Watch, FDA Warning, Fraud Alert, Pharmacy Alert - PharmAlert, Regulators, Scam Alert, Security Alert.
1 comment so far

Buying Prescription Drugs Online May Be Dangerous Says Drug Enforcement Administration

National Association of Boards of Pharmacy (NABP)

Warning

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

From: FDA Center for Drug Evaluation and Research
FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov

Date: November 16, 2009
TO: Chris Walsh
c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD 20903

TO: Chris Walsh
FROM: Food and Drug Administration Internet Pharmacy Task Force
RE: Internet Marketing of Unapproved and Misbranded Drugs
DATE: November 16, 2009

Warning Letter

The United States Food and Drug Administration (FDA) has reviewed your website at trustmeds.com and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act). These products include, but are not limited to, “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Viagra (Brand),” and “Prozac (Generic).” We request that you immediately cease marketing violative products.
These products are drugs under section 201(g) of the Act, 21 U.S.C. § 321(g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:
Unapproved New Drugs
Your firm offers many unapproved new drugs including, but not limited to “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant.” FDA is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated sources do not have the same assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states. Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective.

Rimonabant (also marketed under the name Acomplia) was specifically rejected for FDA approval because it did not meet the statutory requirements for safety and effectiveness. In June 2007, the FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted not to recommend approval of the drug because of increased risk of neurological and psychiatric side effects including seizures, depression, anxiety, insomnia, aggressiveness, and suicidal thoughts among patients. Accordingly, the “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant” dispensed through your website are “new drugs,” as defined by section 201(p) of the Act, 21 U.S.C. § 321(p).
Under sections 301(d) and 505(a) of the Act, 21 U.S.C. §§ 331(d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved application is in effect for it. Your sale of several products, including “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant” without approved applications violates these provisions of the Act.
Misbranded Drugs
Your website offers numerous products, including but not limited to “Viagra (Brand)” and “Prozac (Generic)” for sale without requiring that the products be dispensed under a prescription from a duly licensed practitioner. Therefore, the drugs are misbranded under section 503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301(a), 301(b), and 301(k) of such Act, 21 U.S.C. §§ 331(a), 331(b), and 331(k).
Further, your website offers products for sale and states that they are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act. Therefore, these products are misbranded under section 502(a)of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.
The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301(a) of the Act, 21 U.S.C. § 331(a).
This letter is not intended to identify all of the ways in which your activities might be in violation of United States law. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations. You should take prompt action to correct the violations noted above. Failure to correct these violations promptly may result in regulatory action, including but not limited to, seizure and/or injunction without further notice. Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov or (301) 796-3110.
Sincerely,

/S/
Deborah M. Autor, Esq.
Director
Office of Compliance
Center for Drug Evaluation and Research

Other Domains Associated With This Group

us-pharmacy.us
trusted-tabs.us
terameds.org
rxmeds-online.net
buyonlineviagra.net
usrxmeds.net
mypillshop.net
buycanadianpharmacy.net
dutyfreemeds.net
happypharmacy.net
cheapestcigarettes.net
buy-order.net
drug-pharmacy.net
rx-market.info
preferredpharma.com
prescriptionsintl.com
quickgeneric.com
1st-european-pharmacy.com
e-pharmacy-usa.com
webrxmed.com
online-pharmacy-no-prescription.com
pillsshipping.com
buycanadianpharmacy.com
cheapdrugsmd.com
domain-admin-central.com
aprixe.com
pricedpills.com
medscourier.com
de-pharma.com
usenetload.com
my-pill.com
rxgenericsstore.com
herbalmedsonline.com
global-generics-source.com
rxcalm.com
allgenericpills.com
nonrxmeds.com
pharmacytouch.com
mypillsfinder.com
bestrxdeal.com
phentermine-online-shop.com
bitrhconrtol.com
2009drugs.com
americanmedsdirect.com
first-canadian-drugstore.com
first-canadian-pharmacy.com
first-canadian-meds.com
first-canadian-pharma.com
rxbynet.com
top-hotpills.com
4cheaprx.com
top-uspharm.com
discountwebmeds.com
doctorphentermine.com
scandiamedic.com
reliable-medicines.com
drugstrain.com
online-generic-pharmacy.com
buy-generic-drugs-online.com
medrugsleader.com
pillspricedright.com
dprixe.com
drugdeliverycenter.com
pharmacy-usa.biz
ukmed.biz
duty-free-cigarettes.biz

FDA Warns of Bogus Pharmacy Sites November 22, 2009

Buying Prescription Drugs Online May Be Dangerous Says Drug Enforcement Administration

National Association of Boards of Pharmacy (NABP)

Warning

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

From: FDA Center for Drug Evaluation and Research
FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov

Date: November 16, 2009

TO: Med Light LTD
37 Rectory Lane
PO Box 2063
Belize City, Belize

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES

FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD 20903

TO: Med Light LTD

FROM: Food and Drug Administration Internet Pharmacy Task Force

RE: Internet Marketing of Unapproved and Misbranded Drugs

DATE: November 16, 2009

Warning Letter

The United States Food and Drug Administration (FDA) has reviewed your websites at

and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act). These products include, but are not limited to, “Acomplia (Brand),” “Acomplia (Generic),” “Rimonabant,” “Viagra (Brand),” “Cialis (Brand),” and “Prozac (Generic).” We request that you immediately cease marketing violative products.

These products are drugs under section 201 (g) of the Act, 21 U.S.C. § 321(g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:

Unapproved New Drugs

Your firm offers many unapproved new drugs including, but not limited to “Acomplia (Brand),” “Acomplia (Generic),” and “Rimonabant.” FDA is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated sources do not have the same assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states.

Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective. Rimonabant (also marketed under the name Acomplia) was specifically rejected for FDA approval because it did not meet the statutory requirements for safety and effectiveness. In June 2007, the FDA Endocrinologic and Metabolic Drugs Advisory Committee unanimously voted not to recommend approval of the drug because of increased risk of neurological and psychiatric side effects including seizures, depression, anxiety, insomnia, aggressiveness, and suicidal thoughts among patients. Accordingly, the “Acomplia (Brand),” “Acomplia (Generic),” and “Rimonabant” dispensed through your websites are “new drugs,” as defined by section 201 (p) of the Act, 21 U.S.C. § 321(p).

Under sections 301 (d) and 505(a) of the Act, 21 U.S.C. §§ 331 (d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved application is in effect for it. Your sale of several products, including “Acomplia (Brand),” “Acomplia (Generic),” and “Rimonabant” without approved applications violates these provisions of the Act.

Misbranded Drugs

Your websites offer product for sale without requiring that the products be dispensed under a prescription from a duly licensed practitioner, including, but not limited to “Viagra (Brand),” “Cialis (Brand),” and “Prozac (Generic).” Therefore, the drugs are misbranded under section 503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301(a), 301(b), and 301(k) of such Act, 21 U.S.C. §§ 331(a), 331(b), and 331(k).

Further, your websites offer products for sale and state that they are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act. Therefore, these products are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.

The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301(a) of the Act, 21 U.S.C. § 331(a).

This letter is not intended to identify all of the ways in which your activities might be in violation of United States law. It is your responsibility to ensure that all products marketed by your firm are in compliance with the Act and its implementing regulations. You should take prompt action to correct the violations noted above. Failure to correct these violations promptly may result in regulatory action, including but not limited to, seizure and/or injunction without further notice.

Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAInternetPharmacyTaskForce-CDER@fda.hhs.gov or (301) 796-3110.

Sincerely,

/S/
Deborah M. Autor, Esq.
Director
Office of Compliance
Center for Drug Evaluation and Research

CC:
Chris Walsh c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
www.refill-rx-meds.com
www.brand-meds.com
www.rx-easy-pharmacy.com

Janis Larsen c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
www.buy-american-pharma.com
www.online-pharma-rx.com

Gordon Mcleod c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
www.first-american-pharmacy.com
www.secure-rx-refills.com

Katherine Wainscott c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
www.brand-pharma.com

PrivacyProtect.org
Domain Administrator
contact@privacyprotect.org
www.american-pharm.com
www.first-swiss-meds.com

Jacqueline Sockley c/o Dyndadot Privacy
PO Box 701
San Mateo, CA 94401
www.rx-Iife.com

Domains by Proxy, Inc.
15111 N. Hayden Road
Ste 160 PMB 353
Scottsdale Arizona 85260
www.quickgeneric.com

Other Domains Associated With This Group

healthonlineshop.org
rollinrollin.net
newhealthshop.net
generics-pharm.net
megarx.net
cheapphentermine.com
mediwax.com
buy-refill-online.com
easy-refill-online.com
my-refill-club.com
improved-generic.com
global-genrics-source.com
global-rx-pharm.com
us-value-pharm.com
i-want-rx.com
global-meds-direct.com
pharma-herbal.com
first-refill-club.com
first-refill-online.com
approved-refill-club.com
refill-club.com
refill-online.com
hotrxsales.com
lifestyle-generic.com
refill-rx-now.com
direct-rx-refill.com
central-rx-refill.com
my-refill-drugstore.com
secure-rx-refills.com
global-drugstore.com
refill-drugstore.com
pharma-discounts.com
global-pharma-rx.com
wehatebaseball.com
checkfornews.com
total-pharma.com

us-pharmacy.us
trusted-tabs.us
terameds.org
rxmeds-online.net
buyonlineviagra.net
usrxmeds.net
mypillshop.net
buycanadianpharmacy.net
dutyfreemeds.net
happypharmacy.net
cheapestcigarettes.net
buy-order.net
drug-pharmacy.net
rx-market.info
preferredpharma.com
prescriptionsintl.com
quickgeneric.com
1st-european-pharmacy.com
e-pharmacy-usa.com
webrxmed.com
online-pharmacy-no-prescription.com
pillsshipping.com
buycanadianpharmacy.com
cheapdrugsmd.com
domain-admin-central.com
aprixe.com
pricedpills.com
medscourier.com
de-pharma.com
my-pill.com
rxgenericsstore.com
herbalmedsonline.com
global-generics-source.com
rxcalm.com
allgenericpills.com
nonrxmeds.com
pharmacytouch.com
mypillsfinder.com
bestrxdeal.com
phentermine-online-shop.com
bitrhconrtol.com
2009drugs.com
americanmedsdirect.com
first-canadian-drugstore.com
first-canadian-pharmacy.com
first-canadian-meds.com
first-canadian-pharma.com
rxbynet.com
top-hotpills.com
4cheaprx.com
top-uspharm.com
discountwebmeds.com
doctorphentermine.com
scandiamedic.com
reliable-medicines.com
drugstrain.com
online-generic-pharmacy.com
buy-generic-drugs-online.com
medrugsleader.com
pillspricedright.com
dprixe.com
drugdeliverycenter.com
pharmacy-usa.biz
ukmed.biz
duty-free-cigarettes.biz

FDA Warns of Bogus Pharmacy Sites November 22, 2009

Buying Prescription Drugs Online May Be Dangerous Says Drug Enforcement Administration

National Association of Boards of Pharmacy (NABP)

Warning

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

From: FDA Center for Drug Evaluation and Research
FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov
Date: November 16, 2009

TO: New Horizons LTD
Prol. Av. Independencia KM 20
Santo Domingo
Dominican Republic

UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD.20903
TO: New Horizons LTD
FROM: Food and Drug Administration Internet Pharmacy Task Force
RE: Internet Marketing of Unapproved and Misbranded Drugs
DATE: November 16, 2009

Warning Letter

The United States Food and Drug Administration (FDA) has reviewed your websites at

and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act). These products include, but are not limited to, “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Viagra (Brand),” “Cialis (Brand),” “Prozac (Generic),” and “Levitra (Brand).” We request that you immediately cease marketing violative products.

These products are drugs under section 201 (g) of the Act, 21 U.S.C. § 321 (g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:

Unapproved New Drugs

Your firm offers many unapproved new drugs including, but not limited to “Acomplia (Generic),” “Acomplia (Brand),” and “Rimonabant.” FDA is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated
sources do not have the same assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states. Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective.

Under sections 301 (d) and 505(a) of the Act, 21 U.S.C. §§ 331 (d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved application is in effect for it. Your sale of several products, including “Acomplia (Generic), “Acomplia (Brand),” and “Rimonabant” without approved applications violates these provisions of the Act.

Misbranded Drugs

Many of your websites sell products, including but not limited to “Viagra (Brand),” “Cialis (Brand)”, “Prozac (Generic),” and “Levitra (Brand)” without requiring that the products be dispensed under a prescription from a duly licensed practitioner. Therefore, the drugs are misbranded under section 503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301(a), 301 (b), and 301(k) of such Act, 21 U.S.C. §§ 331 (a), 331(b), and 331(k).

Further, your websites offer products for sale and state that they are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act.
Therefore, these products are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.

The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301 (a) of the Act, 21 U.S.C. § 331 (a).

Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAlnternetPharmacyTaskForceCDER@ fda.hhs.govor (301) 796-3110.

Sincerely,

/S/
Deborah M. Autor, Esq.
Director
Office of Compliance
Center for Drug Evaluation and Research

Cc:
Chris Walsh c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
top-drugstore. net

John Ruben c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
us-rx-meds.com

PrivacyProtect.org
Domain Admin
contact@privacyprotect.org
american-pharma.com
approved-swiss-pharm.com
approved-swiss-pharma.com
approved-swiss-pharmacy.com
first-swiss-dru gstore.com
first-swiss-pharm .com
first-swiss-pharmacy.com
mexican-pharma.com

Gordon Mcleod c/o Dynadot Privacy
PO Box 701
San Mateo, CA 94401
United States
central-rx-refill.com

Piter Krasnikov
745 Ushakova
Petersburg, 23987
Russian Federation
midas ua@yahoo.com
cheapdrugsmd.com

Domains by Proxy, Inc., DomainsByProxy.com
15111 N. Hayden Rd., Ste 160, PMB 353
Scottsdale, Arizona 85260
PHARMACYTOUCH.COM@domainsbyproxy.com
pharmacytouch.com

WhoisGuard
8939 S. Sepulveda Blvd. #110 – 732
Westchester, CA 90045
lion-rx.com
mypillshop.com

Other Domains Assoiciated With This Group

stimulmedia.us
stimul-media.org
stimulmedia.org
x-traffic.org
indianmeds.org
stimulmedia.net
indianrx.net
pharmaceutical-news.net
stimulmedia.info
anti-fungal-meds.com
anti-headache-meds.com
bp-meds.com
cheap-anti-depressants.com
cheap-ed-drugs.com
cheap-ed-meds.com
cheap-ed-pills.com
cheap-pain-meds.com
discount-ed-meds.com
discount-ed-pills.com
extracheapdrugs.com
gastrointestinal-meds.com
get-your-movie.com
gpills.com
help-me-please.com
mens-best-friends.com
order-cheap-antibiotics.com
order-cheap-cialis.com
order-cheap-levitra.com
pills4boys.com
pr-drugs.com
stimulmedia.com
stimul-media.com
thyroid-meds.com
womens-health-meds.com
deli-drugs.com
delirx.com
delidrugs.com
delhi-drugs.com
delhidrugs.com
delhirx.com
perfect-ed-store.com
top-viagra-store.com
worlds-best-pharmacy.com
worldbestpharmacy.com
ordercheappills.com
bestdealviagra.com
yourpillshere.com
genericsfromindia.com
indian-generics.com
secure-my-card.com
mumbaidrugs.com
my-secure-billing.com
best-cialis-store.com
friendly-ed-pharmacy.com
popular-ed-products.com
best-levitra-store.com
rxpforum.com
rxpblog.com
rxpwiki.com
smok-ox.com
smokox.com
regrowth-plus.com
yagarastock.com
fast-slim.com
naturalexcel.com
hoodiastock.com
fineandchic.com
yourorderhere.com
herbalcustomer.com
billclothes.com
paid4clothes.com
bigp-rx.com
megahoodia400.com
well-sleep.com
purplehoodia800.com
hghgreen.com
garments-replica.com
salezhelp.com
indian-herbals.com
naturalpenisole.com
servized.com
medsbill.com
paid4medz.com
your-pills-online.com
easy-export.biz
farmaforum.biz
pharmforum.biz

FDA Warning – 247meds. com November 22, 2009

Posted by Scrub in Alerts, Bogus Pharmacy Sites, Consumer Alert, Consumer Protection, Consumer Watch, Counterfeit Drugs Alert, FDA Warning, Fraud Alert, Online Pharmacy Alert, Pharmacy Alert - PharmAlert, Regulators, Scam Alert.
add a comment

Buying Prescription Drugs Online May Be Dangerous Says Drug Enforcement Administration

National Association of Boards of Pharmacy (NABP)

Warning

Behind The Online Pharmacy

Today a shadowy, transnational network of illicit drug manufacturers, traders, doctors, Web site operators, spammers and criminals makes up the online pharmacy world.

Buying Medication Online Can Be Safe

From: FDA Center for Drug Evaluation and Research
FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov

Date: November 16, 2009

TO: Ric Deleon
21 Villamor Street
Manila, Manila 2700
bastprices2000@yahoo.com
UNITED STATES DEPARTMENT OF HEALTH AND HUMAN SERVICES
FOOD AND DRUG ADMINISTRATION
ROCKVILLE, MD 20903

TO: Ric Deleon
FROM: Food and Drug Administration Internet Pharmacy Task Force
RE: Internet Marketing of Unapproved and Misbranded Drugs
DATE: November 16, 2009

WARNING LETTER

The United States Food and Drug Administration (FDA) has reviewed your websites at

and has determined that you are offering products for sale in violation of the Federal Food, Drug, and Cosmetic Act (the Act). These products include, but are not limited to, “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,” “Herbal Ambien,” “Herbal Viagra,” “Viagra (Brand),” “Xanax (Brand),” and “Valium (Brand).” We request that you immediately cease marketing violative products.

These products are drugs under section 201 (g) of the Act, 21 U.S.C. § 321 (g), because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or because they are intended to affect the structure or function of the body. Your marketing and distribution of these drugs violate various provisions of the Act, as described below:

Unapproved New Drugs

Your firm offers many unapproved new drugs including, but not limited to Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,· “Herbal Ambien,· and “Herbal Viagra.” FDA
is taking this action against your firm because of the inherent risk in buying unapproved prescription drugs. Unapproved drugs from unregulated sources do not have the same assurance of safety and effectiveness as drugs subject to FDA oversight and have been found to be contaminated, counterfeit, contain varying amounts of active ingredients, or contain different ingredients altogether. For drugs that are regulated by FDA, FDA protections include rigorous scientific standards for prescription drug approval and label review for accuracy and completeness, manufacturing procedures and testing performed under closely controlled conditions at FDA-registered and inspected facilities. In addition, pharmacies and wholesalers who sell or distribute prescription drugs in the U.S. are licensed by the states. Unapproved new drugs delivered to the American public from unregulated sources may not be safe and effective.

You also offer “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” on your websites. Xanax, Ambien, and Viagra are approved drugs well-known for their intended use(s) to treat disease.
Therefore, including these drug names causes “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” to be subject to regulation as drugs under Section 201 (g) of the Act because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease.
Moreover, these products are new drugs, as defined by section 201 (p) of the Act, 21 U.S.C. § 321 (p).

Under sections 301 (d) and 505(a) of the Act, 21 U.S.C. §§ 331 (d) and 355(a), a new drug may not be introduced or delivered for introduction into interstate commerce unless an FDA-approved application is in effect for it. Your sale of several products, including but not limited to “Acomplia (Generic),” “Acomplia (Brand),” “Rimonabant,” “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra,” without approved applications violates these provisions of the Act.

Misbranded Drugs

Your websites offer several products, including but not limited to “Viagra (Brand),” “Xanax (Brand),” and “Valium (Brand),” for sale without requiring that the products be dispensed under a prescription from a duly licensed practitioner. Some of the products available on your website are also controlled substances; the sale of these products is particularly concerning because of the potential for abuse and dependency. Therefore, the drugs are misbranded under section
503(b)(1) of the Act, 21 U.S.C. § 353(b)(1), and are marketed in violation of sections 301 (a), 301 (b), and 301 (k) of such Act, 21 U.S.C. §§ 331 (a), 331 (b), and 331 (k).

Further, your websites offer products for sale and state that they are FDA-approved. As noted above, your products are not FDA-approved and are offered for sale in violation of the Act.
Therefore, these products are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs is false and misleading.

In addition, you offer “Herbal Xanax,” “Herbal Ambien,” and “Herbal Viagra” for sale. These drugs are misbranded under section 502(a) of the Act, 21 U.S.C. § 352(a), because the labeling of the drugs are false and misleading. The labeling are false and misleading because they erroneously suggest that the products contain Xanax, Ambien, and Viagra, which are the proprietary names for FDA-approved products containing the active pharmaceutical ingredients alprazolam,
zolpidem, and sildenafil citrate. Regardless of whether your products contain Xanax, Ambien, or Viagra, the products you are offering for sale are not manufactured by the sponsors of the approved applications for Xanax, Ambien, or Viagra, and it is false and misleading to suggest that
your products are manufactured by that sponsor.

The introduction or delivery for introduction into interstate commerce of these misbranded products violates section 301 (a) of the Act, 21 U.S.C. § 331 (a).

Please notify this office in writing within 15 working days of receipt of this letter of any steps you have taken or will take to correct the noted violations and to prevent their recurrence. If the corrective action(s) cannot be completed within 15 working days, state the reason for the delay and the time within which the correction(s) will be completed. Your response should be sent to FDAlnternetPharmacyTaskForce-CDER@fda.hhs.gov. Please direct any inquiries concerning this letter to FDA’s Internet Pharmacy Task Force at FDAlnternetPharmacyTaskForceCDER@fda.hhs.gov or (301) 796-3110.
Sincerely,

/S/

Deborah M. Autor, Esq.
Director
Office of Compliance